8 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
Behcet's disease - APLS ... Structural - Pelvic masses ... Recurrent #DVT #VTE ... anticoagulation #hematology ... #differential #algorithm
Algorithm for the Management of Ventricular Tachycardia Electrical Storm
ES diagnosed (≥ 3 episodes of VT/ICD therapies
Algorithm for the ... Management of Ventricular ... cardioversion as per ACLS ... of reversible causes ... #Tachycardia #Algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... body mass index; VTE ... #Cancer #Algorithm ... Anticoagulation #Management ... #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... risk of recurrent VTE ... #DOAC #VTE #Malignancy ... Anticoagulation #Management ... #Hematology #Oncology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... Thrombosis and Management ... #Extension #VTE ... #DVT #Hematology ... #Differential #Causes
Adult ACLS - Cardiac Arrest Algorithm - AHA 2020
CPR Quality:
 • Push hard (at least 2
Adult ACLS - Cardiac ... Arrest Algorithm ... 2 minutes. or sooner ... intra-arterial Reversible Causes ... #AHA2020 #management
Adult Cardiac Arrest - ACLS Circular Algorithm - AHA 2020
CPR Quality:
 • Push hard (at least
Cardiac Arrest - ACLS ... Circular Algorithm ... 2 minutes. or sooner ... intra-arterial Reversible Causes ... #AHA2020 #management
Hodgkin's Lymphoma Overview

Hodgkin's lymphoma (HL) is an uncommon hematological malignancy arising from mature B cells. It
of about three cases ... Lymphoma (90-95% of cases ... Increased Serum Copper ... classification #hematology ... #oncology #management